Special ArticlesWorldwide BI and analytics market to reach $16.9 billion in 2016
Global revenue in the business intelligence (BI) and analytics market is forecast to reach $16.9 billion in 2016, an increase of 5.2 percent from 2015, according to the latest forecast from Gartner, Inc. The BI and analytics market is in the final stages of a multiyear shift from IT-led, system-of-record reporting to business-led, self-service analytics. As a result, the modern business intelligence and analytics (BI&A) platform has emerged to meet new organizational requirements for accessibility, agility and deeper analytical insight.Read More
Special ArticlesYouth or experience: Which is more valuable in the boardroom?
Approximately half of the companies listed with Standard & Poor have adopted policies mandating retirement based on age. A new study from the University of Missouri has found that although these mandatory retirement polices represent an effective way to address underperforming CEOs, accumulated job experience improves performance and counters age-related declines.Read More
Special ArticlesWinners in digital economy place people first
Leading companies that develop a people first approach will win in today’s digital economy, according to the latest global technology trends report from Accenture. As technology advancements accelerate at an unprecedented rate – dramatically disrupting the workforce – companies that equip employees, partners and consumers with new skills can fully capitalize on innovations. Those that do will have unmatched capabilities to create fresh ideas, develop cutting-edge products and services and disrupt the status quo.Read More
Healthcare: The quiet reform
If you want to know where healthcare is headed in the United States, ignore the political partisans and pundits and pay attention to what’s happening on the ground. Long before the Patient Protection and Affordable Care Act became both law and a political football nearly two years ago, the industry quietly began reforming itself, driven by the purist of interests: survival and prosperity, in that order.
For this special issue of Analytics, we invited a variety of analysts who work or consult in the healthcare sector to contribute articles based on their particular experience and expertise. One of the first invitations went out to Tom Davenport, who literally wrote the book on analytics (“Competing on Analytics”). Tom contributed a piece on one of the most significant problems facing the healthcare industry as it charges into the future: analytical integration.
We also interviewed a handful of industry leaders and stakeholders from the provider, payer and pharmaceutical segments to give us a well-rounded view of the rapidly changing healthcare landscape (“Analytics & the future of healthcare”). The one message we kept hearing over and over again from all sides was this: Skyrocketing costs have rendered the current U.S. healthcare system “unsustainable,” market forces are calling for a performance-based system, analytics are crucial to this paradigm shift from “volume” to “value,” and the transformation is inevitable. In other words, the 2012 U.S. presidential election might slow down or modify healthcare reform (depending on the results), but it won’t stop it.
I would like to take this opportunity to acknowledge Atanu Basu, founder and CEO of Ayata, a Prescriptive Analytics® software company headquartered in Austin, Texas. Atanu, who has a personal and professional interest in the intersection of analytics and healthcare, brought many of the contributors to this special issue to my attention. An enthusiastic supporter of all things analytic, Atanu also served as a co-author of the introductory article to this special issue.
As several of the articles in the issue point out, healthcare providers were – for many years and many reasons – reluctant to embrace analytics, but now the industry appears on the verge of leapfrogging to the forefront of analytical applications. Needless to say, it’s a welcomed development and sets the stage for a promising future – for analysts, for the healthcare industry, and most of all, for patients.
As always, we look forward to your comments.